BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18709514)

  • 1. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications.
    Kunitake H; Hodin R; Shellito PC; Sands BE; Korzenik J; Bordeianou L
    J Gastrointest Surg; 2008 Oct; 12(10):1730-6; discussion 1736-7. PubMed ID: 18709514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis.
    Gainsbury ML; Chu DI; Howard LA; Coukos JA; Farraye FA; Stucchi AF; Becker JM
    J Gastrointest Surg; 2011 Mar; 15(3):397-403. PubMed ID: 21246415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis.
    Ferrante M; D'Hoore A; Vermeire S; Declerck S; Noman M; Van Assche G; Hoffman I; Rutgeerts P; Penninckx F
    Inflamm Bowel Dis; 2009 Jul; 15(7):1062-70. PubMed ID: 19161179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab and complications after colectomy in patients with ulcerative colitis.
    Bregnbak D; Mortensen C; Bendtsen F
    J Crohns Colitis; 2012 Apr; 6(3):281-6. PubMed ID: 22405163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?
    Canedo J; Lee SH; Pinto R; Murad-Regadas S; Rosen L; Wexner SD
    Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric chronic ulcerative colitis: does infliximab increase post-ileal pouch anal anastomosis complications?
    Kennedy R; Potter DD; Moir C; Zarroug AE; Faubion W; Tung J
    J Pediatr Surg; 2012 Jan; 47(1):199-203. PubMed ID: 22244417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of disease may predict response to infliximab in pediatric ulcerative colitis.
    Mir SA; Nagy-Szakal D; Smith EO; Gilger MA; Kellermayer R
    J Clin Gastroenterol; 2014 Mar; 48(3):248-52. PubMed ID: 24129407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study.
    Flasar MH; Johnson T; Roghmann MC; Cross RK
    Inflamm Bowel Dis; 2008 Jan; 14(1):13-9. PubMed ID: 17973305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the impact of infliximab use on surgical outcomes in pediatric Crohn's disease.
    Abbas PI; Peterson ML; Fallon SC; Lopez ME; Wesson DE; Walsh SM; Kellermayer R; Rodriguez JR
    J Pediatr Surg; 2016 May; 51(5):786-9. PubMed ID: 26944181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-year, single tertiary care center experience on the durability of infliximab in pediatric inflammatory bowel disease.
    Vahabnezhad E; Rabizadeh S; Dubinsky MC
    Inflamm Bowel Dis; 2014 Apr; 20(4):606-13. PubMed ID: 24552827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
    Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
    Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery.
    Bordeianou L; Kunitake H; Shellito P; Hodin R
    Int J Colorectal Dis; 2010 Mar; 25(3):401-4. PubMed ID: 19798508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Complications in Children With Crohn Disease Treated With Infliximab.
    Zimmerman LA; Saites CG; Bairdain S; Lien C; Zurakowski D; Shamberger RC; Linden BC; Bousvaros A
    J Pediatr Gastroenterol Nutr; 2016 Sep; 63(3):352-6. PubMed ID: 27377833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study.
    Barberio B; Zingone F; D'Incà R; Rovigo L; Bertani L; Bodini G; Ghisa M; Gubbiotti A; Massimi D; Lorenzon G; Savarino EV
    Clin Transl Gastroenterol; 2020 May; 11(5):e00177. PubMed ID: 32677808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.
    Alsaleh A; Gaidos JK; Kang L; Kuemmerle JF
    Dig Dis Sci; 2016 Sep; 61(9):2602-7. PubMed ID: 27126205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment.
    Krajcovicova A; Batovsky M; Gregus M; Hlista M; Durina J; Leskova Z; Sturdik I; Gojdic M; Jalali Y; Koller T; Toth J; Huorka M; Hlavaty T
    Acta Gastroenterol Belg; 2018; 81(4):465-470. PubMed ID: 30645913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.
    Appau KA; Fazio VW; Shen B; Church JM; Lashner B; Remzi F; Brzezinski A; Strong SA; Hammel J; Kiran RP
    J Gastrointest Surg; 2008 Oct; 12(10):1738-44. PubMed ID: 18709420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014.
    Larsen L; Drewes AM; Broberg MCH; Fallingborg J; Jacobsen BA; Jensen TB; Jess T
    Inflamm Bowel Dis; 2018 Jan; 24(2):433-439. PubMed ID: 29361095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study.
    Steenholdt C; Molazahi A; Ainsworth MA; Brynskov J; Østergaard Thomsen O; Seidelin JB
    Scand J Gastroenterol; 2012 May; 47(5):518-27. PubMed ID: 22375898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.